We further evaluated the pathological characteristics, including HER2, MMR and PD-L1 status, for their association with IL-6 or irAEs in GAC and ESCC patients, but no statistically significant difference could be archived (data not shown). Here, ERBB2 is linked to esophageal squamous cell carcinoma.